Presence of circulating anti-H-2 antibody and cell-mediated precursors in successful DBA/2J-plus- (DBA/2J X C3H/HeJ) F1 parabiosed mice
Drell, D.W.; Carlson, G.A.; Wegmann, T.G.
Journal of Immunology 123(5): 2319-2327
1979
ISSN/ISBN: 0022-1767 PMID: 385781 Document Number: 140365
Document emailed within 1 workday
Related Documents
Loughman, B.E.; Farrar, J.J.; Nordin, A.A. 1974: Presence of antibody-forming cell precursors in the mouse adherent spleen cell population Journal of Immunology 112(1): 430-432Maeda, T.; Nomoto, K. 1995: Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels Journal of Rheumatology 22(12): 2259-2265
Marshall, M.J.; Menage, P.J.; Nisbet, N.W. 1979: The dynamics of red cell chimaerism in histoincompatible parabiosed mice Experimental Hematology 7(8): 425-434
Bemelmans, M.H.; Abramowicz, D.; Gouma, D.J.; Goldman, M.; Buurman, W.A. 1994: In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies Journal of Immunology 153(2): 499-506
Sidorenko, A.V.; Andrianova, L.F. 1984: Effect of hydroxyurea on the number of hematopoietic stem cells, stromal cell precursors and cell precursors of thymus lymphoid tissue in the bone marrow of mice during aging Tsitologiia 26(7): 813-817
Gordon, J.; Murgita, R.A.; Tomasi, T.B. 1975: The immune response of mice treated with anti-mu antibodies: the effect on antibody-forming cells, their precursors and helper cells assayed in vitro Journal of Immunology 114(6): 1808-1812
Guerra, F.; Bellido, C.; Aguilar, R.; Jurado, R.; Garrido, F.; Sánchez Guijo, P. 1981: Inhibition of antibody-dependent cell-mediated cytotoxicity (CIA) as a technic for measuring circulating immune complexes in autoimmune diseases Revista Clinica Espanola 163(6): 397-402
Ruangkanchanasetr, P.; Srichaikul, T.; Supaporn, T. 2012: Triple immunosuppressive therapy can accelerate the recovery of antibody-mediated pure red cell aplasia and allow successful concurrent resumption of erythropoietin Journal of the Medical Association of Thailand 95 Suppl. 5: S92-S95
Arimura, Y. 1982: The presence of anti-T gamma cell antibody and its role in the pathogenesis of nephrotic syndrome with primary glomerulonephritis Nihon Jinzo Gakkai Shi 24(11): 1205-1216
Murayama, T.; Koshimura, S.; Natsuume-Sakai, S. 1985: Production of potent immunoglobulins by group a streptococcus for antibody dependent cell-mediated cytotoxicity in mice Japanese Journal of Experimental Medicine 55(6): 225-232
Bradley, T.P.; Bonavida, B. 1982: Mechanism of cell-mediated cytotoxicity at the single cell level. IV. Natural killing and antibody-dependent cellular cytotoxicity can be mediated by the same human effector cell as determined by the two-target conjugate assay Journal of Immunology 129(5): 2260-2265
Bright, R.K.; Shearer, M.H.; Kennedy, R.C. 1994: Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity Journal of Immunology 153(5): 2064-2071
Austin, R.M.; Daniels, C.A. 1976: Inhibition by rheumatoid factor, anti-FC, and staphylococcal protein a of antibody-dependent cell-mediated cytolysis against Herpes simplex virus-infected cells Journal of Immunology 117(2): 602-607
Hall, L.R.; Lass, J.H.; Diaconu, E.; Strine, E.R.; Pearlman, E. 1999: An essential role for antibody in neutrophil and eosinophil recruitment to the cornea: B cell-deficient (microMT) mice fail to develop Th2-dependent, helminth-mediated keratitis Journal of Immunology 163(9): 4970-4975
Sherr, D.H.; Braun, J.; Dorf, M.E. 1987: Idiotype-specific Ly-1 B cell-mediated helper activity: hybridomas that produce anti-idiotype antibody and nonimmunoglobulin lymphokine(s)1 Journal of Immunology 138(7): 2057-2062
Tanaka, K. 2005: Diagnostic tests: Anti-Purkinje cell antibody (Anti-Yo/type 1 antibody) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 7): 479-482
Ganley-Leal, L.M.; Mwinzi, P.N.M.; Cetre-Sossah, C.B.; Andove, J.; Hightower, A.W.; Karanja, D.M.S.; Colley, D.G.; Secor, W.E. 2006: Higher percentages of circulating mast cell precursors correlate with susceptibility to reinfection with Schistosoma mansoni American Journal of Tropical Medicine and Hygiene 75(6): 1053-1057
McBride, W.H.; Howie, S. 1984: Paradoxical presence of T cell anergy during successful T cell-dependent tumour immunotherapy: characterization of a state of T cell 'amnaesia' following systemic administration of C. parvum Clinical and Experimental Immunology 57(1): 139-148
Hirsch, R.; Bluestone, J.A.; Bare, C.V.; Gress, R.E. 1991: Advantages of F(ab')2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice Transplantation Proceedings 23(1 Part 1): 270-271
Levy, P.C.; Looney, R.J.; Shen, L.; Graziano, R.F.; Fanger, M.W.; Roberts, N.J.; Ryan, D.H.; Utell, M.J. 1990: Human alveolar macrophage FcR-mediated cytotoxicity. Heteroantibody- versus conventional antibody-mediated target cell lysis Journal of Immunology 144(10): 3693-3700